DarioHealth Corp reports results for the quarter ended in December - Earnings Summary

DarioHealth

28/03/2024 13:31

* DarioHealth Corp  DRIO.OQ  reported a quarterly adjusted
loss
of 50 cents​​ per share for the quarter ended in December,
higher than the same quarter last year, when the company
reported EPS of -51 cents.  The mean expectation of
three analysts for the quarter was for a loss of 54 cents per
share. 
    * Revenue fell 46.9% to $3.62 million from a year ago;
analysts
expected $3.57 million. 
    * DarioHealth Corp's reported EPS for the quarter was a loss
of 50
cents​.
    * The company reported a quarterly loss of $14.29 million.
    * DarioHealth Corp shares had fallen by 11.6% this quarter.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 1.9%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the medical
equipment,
supplies & distribution peer group is also "buy"

Wall Street's median 12-month price target for DarioHealth Corp
is $5.00 
This summary was machine generated from LSEG data March 28 at
01:31 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2023      -0.54          -0.50          Beat
 Sep. 30 2023      -0.46          -0.49          Missed
 Jun. 30 2023      -0.52          -0.58          Missed
 Mar. 31 2023      -0.50          -0.45          Beat